Morphine Inhibits Glutamate Exocytosis from Rat Cerebral Cortex Nerve Terminals (Synaptosomes) by Reducing Ca2+ Influx

Synapse

Volumn 51, Issue 2, 2004, Pages 83-90

  Yang, Tsung Tsair ^a   Hung, Chi Feng ^b,c   Lee, Yih Jing ^b   Su, Ming Jai ^c   Wang, Su Jane ^b  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cerebro cortical synaptosomes; Glutamate exocytosis; Morphine; Neuroprotection; Presynaptic calcium influx

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOPYRIDINE; CALCIUM CHANNEL; CALCIUM ION; CANNABINOID 1 RECEPTOR; GLUTAMIC ACID; IONOMYCIN; IONOPHORE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE ANTAGONIST; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOPLASM; DEPOLARIZATION; DRUG MECHANISM; EXOCYTOSIS; MALE; NERVE CELL MEMBRANE; NERVE ENDING; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

4-AMINOPYRIDINE; ANALGESICS, OPIOID; ANIMALS; BENZOTHIAZOLES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CARBOCYANINES; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EXOCYTOSIS; FLUOROMETRY; FURA-2; GLUTAMIC ACID; IONOMYCIN; IONOPHORES; MALE; MEMBRANE POTENTIALS; MORPHINE; MORPHOLINES; NALOXONE; NAPHTHALENES; NARCOTIC ANTAGONISTS; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

EID: 0346250855     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10290     Document Type: Article

References (35)

1. Bartlett SE, Smith MT. 1996. Effects of morphine-3-glucuronide and morphine on the K+-evoked release of [3H]-glutamic acid and [14C]-gamma-aminobutyric acid from rat brain synaptosomes. Life Sci 58:447-454.
2. Bradford HF, Crowder JM, White EJ. 1986. Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices. Br J Pharmacol 88:87-93.
3. Cardenas HL, Ross DH. 1976. Calcium depletion of synaptosomes after morphine treatment. Br J Pharmacol 57:521-526.
4. Chang KJ, Cooper BR, Hazum E, Cuatrecasas P. 1979. Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol Pharmacol 16:91-104.
5. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
6. Choi DW, Rothman SM. 1990. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13:171-182.
7. Coutinho-Netto J, Abdul-Ghani AS, Bradford HF. 1982. Morphine suppression of neurotransmitter release evoked by sensory stimulation in vivo. Biochem Pharmacol 31:1019-1023.
8. Dhaliwal D, Bradford HF. 1982. Inhibition of depolarization-coupled calcium fluxes and transmitter release in vitro by morphine. FEBS Lett 144:89-92.
9. Ding YQ, Kaneko T, Nomura S, Mizuno N. 1996. Immunohistochemical localization of μ-opioid receptors in the central nervous system of the rat. J Comp Neurol 367:375-402.
10. 2(5). Brain Res 462:67-75.
11. Grynkiewicz G, Poenie M, Tsien RY. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
12. Harrison JM, Allen RG, Pellegrino MJ, Williams JT, Manzoni OJ. 2002. Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission. J Neurophysiol 87:2464-2470.
13. Kanjhan R. 1995. Opioids and pain. Clin Exp Pharmacol Physiol 22:397-403.
14. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ. 1994. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350: 412-438.
15. Nicholls DG, Sihra TS. 1986. Synaptosomes possess an exocytotic pool of glutamate. Nature 32:772-773.
16. Nicol B, Rowbotham DJ, Lambert DG. 1996. mu- and kappa-opioids inhibit K+ evoked glutamate release from rat cerebrocortical slices. Neurosci Lett 218:79-82.
17. Ostermeier AM, Schlosser B, Schwender D, Sutor B. 2000. Activation of mu- and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons. Anesthesiology 93: 63-93.
18. Pasternak GW. 1993. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18.
19. Perkinton, MS, Sihra, TS. 1998. Presynaptic GABAB receptor modulation of glutamate exocytosis from rat cerebrocortical nerve terminals: Receptor decoupling by protein kinase C. J Neurochem 70: 1513-1522.
20. Rhim H, Miller RJ. 1994. Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J Neurosci 14:7608-7615.
21. Rothman SM, Olney JW. 1986. Glutamate and pathophysiolology of hypoxia-ischemic brain damage. Ann Neurol 19:105-111.
22. Sanchez-Prieto J, Budd DC, Herrero I, Vazquez E, Nicholls DG. 1996. Presynaptic receptors and the control of glutamate exocytosis. Trends Neurosci 19:235-239.
23. Sbrenna S, Marti M, Morari M, Calo G, Guerrini R, Beani L, Bianchi C. 1999. L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors. J Pharmacol Exp Ther 291:1365-1371.
24. Scanziani M, Gahwiler BH, Thompson SM. 1995. Presynaptic inhibition of excitatory synaptic transmission by muscarinic and metabotropic glutamate receptor activation in the hippocampus: are Ca2+ channels involved? Neuropharmacology 34:1549-1557.
25. Sihra TS. 1997. Protein phosphorylation and dephosphorylation in isolated nerve terminals (synaptosomes). In: Hemmings Jr HC, editor. Regulatory protein modification: techniques and protocols. Totowa, NJ: Humana. p 67-119.
26. Sihra TS, Nichols RA. 1993. Mechanisms in the regulation of neurotransmitter release from brain nerve terminals: current hypotheses. Neurochem Res 18:47-58.
27. Sihra TS, Bogonez E, Nicholls DG. 1992. Localized Ca2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release. J Biol Chem 267:1983-1989.
28. Takemori AE, Portughese PS. 1984. Comparative antagonism by naltrexone and naloxone of μ, κ and δ agonists. Eur J Pharmacol 104:101-104.
29. Tibbs GR, Barrie AP, Van Mieghem FJ, Mcmahon HT, Nicholls DG. 1989. Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J Neurochem 53:1693-1699.
30. Ueda M, Sugimoto K, Oyama T, Kuraish Y, Satoh, M. 1995. Opioidergic inhibition of capsaicin-evoked glutamate release from rat spinal dorsal horn slices. Neuropharmacology 34:303-308.
31. Vlaskovska M, Schramm M, Nylander I, Kasakov L, You ZB, Herrera-Marschitz M, Terenius L. 1997. Opioid effects on 45Ca2+ uptake and glutamate release in rat cerebral cortex in primary culture. J Neurochem 68:517-524.
32. 1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes. Eur J Pharmacol 469:47-55.
33. Wimpey TL, Chavkin C. 1991. Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron 6:281-289.
34. Wu LG, Saggau P. 1997. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20:204-212.
35. Yamamoto H, Harris RA, Loh HH, Way EL. 1978. Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J Pharmacol Exp Ther 205:255-264.